Yuan Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuan Yan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Affiliated Hospital of Xuzhou Medical University Xuxhou Medical University
1 shared publicationBo Zheng
Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University , Nanjing
1 shared publication- Chengming Sun
Department of Laboratory Center, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, China
1 shared publication - Dawei Niu
School of Computer Science and Information Engineering, Hefei University of Technology Hefei, China
1 shared publication - Fang Miao
Big Data Research Institute Chengdu University,Chengdu,China
1 shared publication - Fei Zhao
University of Chinese Academy of Sciences, Beijing 100049, China
1 shared publication
Latest Publications
- 11 December 2024
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 30 (12)
Ectopic endometrial stromal cell-derived extracellular vesicles encapsulating microRNA-25-3p induce endometrial collagen I deposition impairing decidualization in endometriosis
Endometrial collagen I undergoes dynamic degradation and remodelling in response to endometrial stromal cell (ESC) decidualization and embryo implantation. However, excessive collagen I deposition in the endometrium during the implantation window may impair decidualization, causing embryo implantation failure in patients with endometriosis (EMS). We found that endometrial collagen I expression during the mid-secretory phase was increased in the EMS group of patients. Collagen I stimulation resulted in decreased expression of the decidualization markers prolactin and insulin-like growth factor binding protein-1 in ESCs, impeding ESC transformation to a decidual morphology and decreasing the blastocyst-like spheroid expansion area in vitro. Treatment with extracellular vesicles (EVs) derived from the ectopic ESCs of EMS patients (EMS-EVs) increased collagen I expression in vivo and in vitro and decreased the blastocyst-like spheroid expansion area. Furthermore, EV microRNA (miRNA) sequencing revealed that there were 40 upregulated and 77 downregulated miRNAs in EMS-EVs when compared to the EVs derived from ESCs in the endometrium of control patients (CTL-EVs), including increased expression of miR-25-3p that targets phosphatase and tensin homolog (PTEN). We also found that PTEN expression was decreased and p-Akt expression was increased in the endometrium of EMS patients and EMS-EV-treated ESCs. miR-25-3p transfected ESCs exhibited increased collagen I, decreased PTEN, and increased p-Akt. Additionally, an EV uptake study further showed that EMS-EVs were preferentially taken up by ESCs rather than by endometrial epithelial cells. These results suggest that EMS-EVs encapsulating miR-25-3p might be preferentially taken up by eutopic ESCs where they may induce endometrial collagen I deposition to impair ESC decidualization in EMS.
- 11 December 2024
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 30 (12)
Ectopic endometrial stromal cell-derived extracellular vesicles encapsulating microRNA-25-3p induce endometrial collagen I deposition impairing decidualization in endometriosis
Endometrial collagen I undergoes dynamic degradation and remodelling in response to endometrial stromal cell (ESC) decidualization and embryo implantation. However, excessive collagen I deposition in the endometrium during the implantation window may impair decidualization, causing embryo implantation failure in patients with endometriosis (EMS). We found that endometrial collagen I expression during the mid-secretory phase was increased in the EMS group of patients. Collagen I stimulation resulted in decreased expression of the decidualization markers prolactin and insulin-like growth factor binding protein-1 in ESCs, impeding ESC transformation to a decidual morphology and decreasing the blastocyst-like spheroid expansion area in vitro. Treatment with extracellular vesicles (EVs) derived from the ectopic ESCs of EMS patients (EMS-EVs) increased collagen I expression in vivo and in vitro and decreased the blastocyst-like spheroid expansion area. Furthermore, EV microRNA (miRNA) sequencing revealed that there were 40 upregulated and 77 downregulated miRNAs in EMS-EVs when compared to the EVs derived from ESCs in the endometrium of control patients (CTL-EVs), including increased expression of miR-25-3p that targets phosphatase and tensin homolog (PTEN). We also found that PTEN expression was decreased and p-Akt expression was increased in the endometrium of EMS patients and EMS-EV-treated ESCs. miR-25-3p transfected ESCs exhibited increased collagen I, decreased PTEN, and increased p-Akt. Additionally, an EV uptake study further showed that EMS-EVs were preferentially taken up by ESCs rather than by endometrial epithelial cells. These results suggest that EMS-EVs encapsulating miR-25-3p might be preferentially taken up by eutopic ESCs where they may induce endometrial collagen I deposition to impair ESC decidualization in EMS.
- Open Access
- 17 April 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Bevacizumab combined with pemetrexed plus carboplatin or cisplatin in the treatment of malignant pleural effusion of lung cancer : A meta-analysis of randomized controlled trials
INPLASY202240096 Bevacizumab combined with pemetrexed plus carboplatin or cisplatin in the treatment of malignant pleural effusion of lung cancer : A meta-analysis of randomized controlled trials K…
- 17 April 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Open AccessBevacizumab combined with pemetrexed plus carboplatin or cisplatin in the treatment of malignant pleural effusion of lung cancer : A meta-analysis of randomized controlled trials
INPLASY202240096 Bevacizumab combined with pemetrexed plus carboplatin or cisplatin in the treatment of malignant pleural effusion of lung cancer : A meta-analysis of randomized controlled trials K…
- Open Access
- 1 January 2015
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 64 (3) , 034202
Feature extraction and recognition of non-resolved space object from space-based spectral data
天基空间目标观测时, 对于远距离目标, 通常只能得到一个点的相关信息, 包括目标的位置和灰度等, 损失了目标的材料、大小和状态等特征. 代表物体固有属性差异的光谱特性可作为目标特征提取与识别的一种重要手段. 从目标光谱特性的产生特点出发, 综合考虑目标的材料特性、结构特性、背景特性、轨道特性等因素, 建立了目标光谱特性的数学模型, 提出了基于光谱特性数学模型反演计算的目标特征提取与识别方法, 以环境一号卫星缩比模型为例, 进行了典型参数条件下的目标特征提取与识别实验验证, 实验结果验证了建模方法的正确性.
- 1 January 2015
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 64 (3) , 034202
Open AccessFeature extraction and recognition of non-resolved space object from space-based spectral data
天基空间目标观测时, 对于远距离目标, 通常只能得到一个点的相关信息, 包括目标的位置和灰度等, 损失了目标的材料、大小和状态等特征. 代表物体固有属性差异的光谱特性可作为目标特征提取与识别的一种重要手段. 从目标光谱特性的产生特点出发, 综合考虑目标的材料特性、结构特性、背景特性、轨道特性等因素, 建立了目标光谱特性的数学模型, 提出了基于光谱特性数学模型反演计算的目标特征提取与识别方法, 以环境一号卫星缩比模型为例, 进行了典型参数条件下的目标特征提取与识别实验验证, 实验结果验证了建模方法的正确性.
- 1 January 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 97
A Robust Header Compression Method for Ad hoc Network
This paper introduces a robust header compression method for mobile ad hoc networks. The node that implements this algorithm won't need to preserve header context while compressing or decompressing the header. When a packet loses or is corrupted, it will not impact following packets because of the independence of the successive compressed headers. This method can be deployed in point to point mode as well as end to end mode
- 1 January 2006
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 97
A Robust Header Compression Method for Ad hoc Network
This paper introduces a robust header compression method for mobile ad hoc networks. The node that implements this algorithm won't need to preserve header context while compressing or decompressing the header. When a packet loses or is corrupted, it will not impact following packets because of the independence of the successive compressed headers. This method can be deployed in point to point mode as well as end to end mode